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ABSTRACT
Frequency of INherited Disorders database (FIND
base; http://www.findbase.org) records frequencies
of causative genetic variations worldwide. Database
records include the population and ethnic group
or geographical region, the disorder name and
the related gene, accompanied by links to any
related external resources and the genetic variation
together with its frequency in that population. In
addition to the regular data content updates, we
report the following significant advances: (i) the
systematic collection and thorough documenta-
tion of population/ethnic group-specific pharmaco-
genomic markers allele frequencies for 144 markers
in 14 genes of pharmacogenomic interest from
different classes of drug-metabolizing enzymes
and transporters, representing 150 populations
and ethnic groups worldwide; (ii) the develop-
ment of new data querying and visualization tools
in the expanded FINDbase data collection, built
around Microsoft’s PivotViewer software (http://
www.getpivot.com), based on Microsoft Silverlight
technology (http://www.silverlight.net) that facili-
tates querying of large data sets and visualizing
the results; and (iii) the establishment of the first
database journal, by affiliating FINDbase with
Human Genomics and Proteomics, a new open-
access scientific journal, which would serve as a
prime example of a non-profit model for sustainable
database funding.
INTRODUCTION
National and Ethnic Mutation Databases (NEMDBs) are
structured data repositories recording the various spectra
of causative genetic variations for any gene or disease in
different populations and ethnic groups worldwide, also
between distinct ethnic groups within a geographical
region (1). NEMDBs provide data that can be used to,
for example, stratify national molecular diagnostic
services, study human demographic history, gene/
mutation ﬂow and admixture patterns (1). Together with
the central (or core) databases, such as the Online
Mendelian Inheritance in Man [OMIM, http://www3
.ncbi.nlm.nih.gov/omim; (2)] or the Human Gene
Mutation Database [HGMD, http://www.hgmd.org; (3)]
and the locus-speciﬁc databases [LSDBs; (4)], they are the
main components that fall under the banner of ‘genetic
databases’.
We have previously described the development of
FINDbase (Frequency of INherited Disorders database;
http://www.ﬁndbase.org), a relational database pertaining
to frequencies of causative mutations, leading to inherited
disorders in various populations and ethnic groups world-
wide (5). FINDbase contains only summary-level data,
i.e. allele frequencies without any sensitive personal data
of their carriers, in order to preserve anonymity.
Content-wise, FINDbase is the richest among the
NEMDB currently available and, since its establishment
in August 2006, it has been broadly adopted by the scien-
tiﬁc community, as one of the key resources to retrieve
population-speciﬁc information for disease-causing muta-
tions, as indicated by the trafﬁc and the number of
visitors.
*To whom correspondence should be addressed. Tel:/Fax: +30 2610 969 (Ext. 834); Email: gpatrinos@upatras.gr
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as joint First Authors.
D926–D932 Nucleic Acids Research, 2011, Vol. 39, Database issue Published online 27 November 2010
doi:10.1093/nar/gkq1236
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Here, we present signiﬁcant data content updates that
make FINDbase more compelling to a broader user
group. We also present some technological advances
that facilitate data querying and visualization. Finally,
we report the afﬁliation of FINDbase with an open-access
scientiﬁc journal, inaugurating the ﬁrst database journal
currently available.
DATA CONTENT UPDATE
Initial FINDbase data content was acquired from the
European Union FP5 Cystic Fibrosis Thematic Network
Consortium data [http://www.cfnetwork.be; (6)], and
population-speciﬁc mutation frequency data derived
from the PAHdb phenylalanine hydroxylase locus
knowledgebase [http://www.pahdb.mcgill.ca; (7)] and
the HbVar database of human hemoglobin variants and
thalassemia mutations [http://globin.bx.psu.edu/hbvar;
(8)]. These data were curated to identify possible errone-
ous entries and corrected where necessary.
Apart from data curation, we also continued to enrich
FINDbase data collection. To this end, we deposited
in FINDbase population-speciﬁc information from the
A1ATVar database, documenting SEPRINA1 gene
variants (9), for the commonest variants leading to a1-
antitrypsin deﬁciency. Also, we collected information
from individual NEMDBs currently available and
incorporated it into the main FINDbase data collection.
This was the ﬁrst step toward unifying NEMDB contents
into a main population-speciﬁc data repository and imple-
menting data warehousing (currently in progress).
Calculation of mutation frequencies is based on the
most representative study available for each population,
involving sufﬁcient number of patients and controls, since
estimation of mutation frequencies based on multiple
reports has the inherent danger of including redundant
cases that can alter the calculated frequencies.
All data entries were recorded against their corres-
ponding data source. When the allele frequency data
were obtained from published reports, then the corres-
ponding unique PubMedID was recorded. If however,
the data source was a LSDB, then the URL of the corres-
ponding resource was used and/or a unique identiﬁer,
namely the ResearcherID (available from Thomson
ISI; http://www.researcherid.com) of the data curator.
Based on our previous experience, the latter ID not only
facilitates unambiguous identiﬁcation of curated data
when data update or correction is needed, but also
provides incentives to potential contributors of unpub-
lished data to share their data with the broader scientiﬁc
community.
FINDbase data compilation and representation are
subject to copyright and usage principles to ensure that
FINDbase and its contents remain freely available to all
interested individuals.
NEW FEATURES
Apart from the extensive data content curation, correc-
tion and enrichment described above, several new features
have been incorporated into FINDbase. These include the
development of new data querying and visualization
tools, a thorough documentation of population/
ethnic group-speciﬁc pharmacogenomic markers allele
frequencies and the establishment of the ﬁrst database
journal, by afﬁliating FINDbase with a new open-
access scientiﬁc journal. These new features are described
below.
Documentation of population/ethnic group-speciﬁc
pharmacogenomic markers allele frequencies
Pharmacogenomics correlates an individual’s genetic vari-
ation on drug response, by linking his/her gene expression
proﬁle or single nucleotide polymorphisms (SNPs) with a
drug’s toxicity or efﬁcacy, hence aiming to optimize drug
therapy by maximizing efﬁciency and/or minimizing
the chances for adverse drug reactions (ADRs) (10). A
plethora of SNPs have been reported to correlate
with several drugs’ safety or efﬁcacy (also referred to as
pharmacogenomic markers) and the incidence of these
SNPs varies among different populations or ethnic
groups, as expected. However, population- and ethnic
group-speciﬁc allele frequencies of pharmacogenomic
markers are poorly documented and not systematically
collected in structured data repositories. We, therefore,
developed a separate module of FINDbase, pertaining
solely to the documentation of population/ethnic group-
speciﬁc allele frequencies of pharmacogenomic markers
in 14 genes, representing different classes of drug-
metabolizing enzymes and transporters. In addition to
the previous data collection, this new FINDbase module
provides information on 144 pharmacogenomic markers,
representing 150 populations and ethnic groups world-
wide, which have been collected from the curation of
214 scientiﬁc articles, retrieved during a large-scale
targeted scientiﬁc literature search (11). This effort repre-
sents the largest, so far, data collection of population/
ethnic group-speciﬁc pharmacogenomic markers allelic
frequencies, aiming to cover the need that is currently
not fulﬁlled by other pharmacogenomics knowledge-
bases and related resources (12). Hence, this initiative
would assist in the future design and development of
pharmacogenomic testing, toward the advent of
personalized medicine.
Development of new data querying and visualization tool
We have decided to re-develop FINDbase structure
and architecture, driven not only by the recent advances
in the ﬁeld and the new data contents, but also from
the need to facilitate data querying in the expanded
FINDbase data collection. We have, therefore, chosen
to build the existing (causative mutations) and new
(pharmacogenomic markers) FINDbase data sets as
separate modules, with the possibility of integrating
them in a single module soon. The component services
that comprise both modules follow the SOA (13,14) and
the querying interface is built around the PivotViewer
(http://www.getpivot.com), based on Microsoft
Silverlight technology (http://www.silverlight.net), a
recently launched development platform by Microsoft,
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visualizing large data sets. The whole application provides
an elegant, web-based multimedia interface for
population-based genetic variation data collection and re-
trieval. Database records include the population, the
ethnic group and/or the geographic region, the gene
name and its variation parameters, the rare allele
frequencies, accompanied by links to the respective
OMIM and the HGMD (causative mutations module)
or PharmGKB entries (pharmacogenomic markers
module). The entire database schema is depicted in the
Supplementary Figure S1.
The whole system architecture is based on a three-tier
client-server model (15), namely the client application, the
application server and the database server. The n-tier
architecture is a robust model and ﬂexible enough to ag-
gregate multiple information sources and integrate
modular developments. All the database records presented
above are a collection that combines large groups of
similar items. There is a set of ﬁles on a server, and a
local client that has the capability to display them. The
ﬁles are traditionally HTML and image ﬁles. In the col-
lection case, the ﬁles are CXML and Deep
Zoom-formatted (DZC) images (http://msdn.microsoft
.com/en-us/library/cc645077%28VS.95%29.aspx).When
the user browses the collection from a web page, the
PivotViewer uses the Silverlight Control to display the
ﬁles.
The entire FINDbase causative mutations data collec-
tion via PivotViewer is shown in Figure 1A, which enables
the user to interact with large data sets at once.
PivotViewer enables users to smoothly and quickly
arrange FINDbase data collections according to
common characteristics that can be selected from the
data query menu (Figure 1B) and then zoom in for a
closer look, by either ﬁltering the collection to get a
subset of information or clicking on a particular item
(Figure 1C). A display item in the form of a card, with a
chromosomal ﬁgure (derived from http://www.genecards
.org) displaying the gene position, is provided for each
genetic variation, along with a sidebar textbox with
in-depth data concerning the particular genetic vari-
ation and population (Figure 1C). Hyperlinks for each
gene name to OMIM database and HGMD, offer to the
user the possibility of easily accessing additional
information.
In particular, the new FINDbase data querying and
visualization environment enables the user to visualize
and sort, organize and categorize data dynamically and
discover trends across all items, using different views.
For example, a user can perform a query based on the
frequency of the rare allele (Figure 2A). Additional ﬁlter-
ing allows the user to see speciﬁc genetic variants and to
further zoom in a particular population (Figure 2B).
Compound queries can also be formulated. Such queries
would be the identiﬁcation of rare pathogenic mutations
(frequencies 10–30%) in the Hellenic population, sorted
out by gene name. The query output includes 19 alleles
for 7 genes (ATP7B, CYP21, HBA2/HBA1, HBB, LDLR,
MEFV, PAH; Figure 2C).
Afﬁliation to a new scientiﬁc journal: toward a novel
publication modality
In May 2008, FINDbase ofﬁcially became the ﬁrst
database afﬁliated with the open-access journal Human
Genomics and Proteomics (HGP), published by
SAGE-Hindawi (http://www.sage-hindawi.com/journals/
hgp). HGP is a new genomics and systems biology
journal that, in addition to publishing original research
and review articles, includes short descriptions of genetic
data sets pertaining to population/ethnic group-speciﬁc
allele frequencies, namely causative mutations or bio-
markers (pharmacogenomic, forensic markers and so
on). These submissions are also stringently peer-reviewed
and, if accepted, featured in the journal as a Mutation and
Biomarker Dataset with links to the full data set in
FINDbase and the PubMed literature database (16).
As the ﬁrst journal with an afﬁliated database in this
discipline, HGP offers a unique opportunity to authors to
open up access to their research on the characterization of
causative mutation and/or biomarker frequency spectra to
the widest possible community (16). This way, HGP not
only provides a forum for researchers of the post-genomic
era but also increases the chances of human variation data
capture and provides a centralized system for
population-speciﬁc data storage and retrieval.
It is envisaged that HGP will provide the proof of prin-
ciple for closely related efforts toward developing other
‘database journals’. Also, the HGP–FINDbase afﬁliation
can serve as a non-proﬁt model for sustainable database
funding, in a ﬁeld that still suffers signiﬁcantly from the
lack of long-term funding opportunities for genetic
database projects (17).
CONCLUSIONS AND FUTURE PERSPECTIVES
FINDbase is a comprehensive source of information on
the extant genetic heterogeneity of different populations,
documenting causative mutation and pharmacogenomic
marker allele frequency data, aiming to be further estab-
lished as a reference repository of such information world-
wide. Database access is free of charge and there are no
registration requirements for data querying.
FINDbase will continue to be updated and data collec-
tion will be further enriched. To this end, our efforts are
facilitated by our participation to one of the leading
database projects worldwide, namely the GEN2PHEN
project (http://www.gen2phen.org) funded by the
European Commission, ensuring not only interaction
with the ﬁeld’s leading experts, but also funding that is
secured for a further 3-year period. Also, FINDbase is a
key component of the Human Variome Project [http://
www.humanvariomeproject.org, (18)], an international
initiative aiming to document genetic variation worldwide.
In particular, our group has taken the lead in establishing
recommendations and guidelines to develop nation-wide
projects to document the genetic heterogeneity in develop-
ing countries (19), an effort that will be further facilitated
by the provision of the ETHNOS software (20), as an aid
to develop NEMDBs in these populations. In addition,
as of early 2007, FINDbase is afﬁliated with HGMD
D928 Nucleic AcidsResearch, 2011, Vol.39, Database issueFigure 1. The updated FINDbase querying and visualization tool. (A) Overview of the entire FINDbase causative mutation module data collection,
based on Microsoft’s PivotViewer. The querying interface is shown on the left and the output option can be selected at the top-right corner of
the screen. The different entries are shown as colored boxes, presented as display items (see below). The user can zoom in for a closer look or click
on a particular item to get more in-depth information. (B) Detail of the FINDbase querying interface. (C) Display items provided for each causative
mutation, accompanied by a sidebar textbox with in-depth data concerning the particular mutation and population. Each item includes the name
of the allele in its ofﬁcial Human Genome Variation Society (HGVS) or other nomenclature systems, if available, the population for which this
information is available (shown by the country’s ﬂag) and a chromosomal map, where the gene’s position is indicated. Hyperlinks for each gene to
OMIM database offer to the user the possibility of easily accessing additional information. Finally, each item displays the corresponding PubMed
and Researcher IDs, if applicable.
Nucleic Acids Research, 2011,Vol.39, Database issue D929Figure 2. FINDbase sample queries. (A) FINDbase causative mutation module data content sorted using the columns option (see top-right corner of
the screen), according to rare allele frequency (0–100%). The user can select a speciﬁc column to retrieve more speciﬁc information. (B) Display of
the mutant alleles in the Israeli population sorted out by gene name (indicated with an arrow). The query returns 90 alleles in equal number of
display items. (C) Query formulation to retrieve the rare alleles in the Hellenic population with an allelic frequency between 10.08% and 30.05%
(indicated with an arrow). The query returns 19 alleles in equal number of display items, sorted out in columns arranged by Gene name (arrow). The
total number of alleles is also shown in the query box.
D930 Nucleic AcidsResearch, 2011, Vol.39, Database issue(http://www.hgmd.org) with the inclusion of bi-directional
links from FINDbase records to HGMD and vice versa.
Last, but not least, the afﬁliation with HGP is also
expected to increase data inﬂux into FINDbase, by
providing incentives to potential contributors and re-
searchers to submit their data to FINDbase, while at the
same time prevents population-based allele frequency data
from being lost or kept unpublished. As a result, since
December 2006 when FINDbase was ofﬁcially announced
(5), we have recorded over 70000 accesses to the query
page from unique IP addresses spanning over 100
countries worldwide (including .com, .org, .net and .gov
URLs), while many users frequently contact the adminis-
trator to report missing information for existing variants
and pinpoint inconsistencies and/or erroneous entries.
This is particularly important, since the user input
improves data quality and accuracy.
Regarding software upgrade, we will soon dispatch a
new freely available version of the ETHNOS software,
as an off-the-shelf solution to establish new NEMDBs.
We anticipate that the existing NEMDBs available at
the Golden Helix Server [http://www.goldenhelix.org;
(21)] as well as those that will be derived from
FINDbase will migrate to the new version of the
ETHNOS software in mid-2011. This new software
version will also include some new features, namely: (i) a
content management system based on the
Model-View-Controller (MVC) design pattern and alter-
native data visualization interfaces and online data
handling functionalities, in order to enhance the data-
base’s performance and user interaction features; (ii)
data exposure through web services based on the oData
protocol (http://www.odata.org); and (iii) expanded
viewing orientation of the application’s interface,
providing a spatiotemporal data viewing dimension.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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